Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Australian Ovarian Cancer Study, Management Group, Project and Data Managers, Research Nurses and Assistants, Clinical and Scientific Collaborators, GAMuT Collaborators

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses'. Together they form a unique fingerprint.

Medicine & Life Sciences